Clinical trial
Infliximab Therapy in Patients With Refractory Polymyalgia Rheumatica: a Double Blind Placebo Controlled Trial
NCT01423591 is registered in ClinicalTrials.gov with Hospital Universitario Marqués de Valdecilla as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Infliximab Therapy in Patients With Refractory Polymyalgia Rheumatica: a Double Blind Placebo Controlled Trial
- Lead sponsor
- Hospital Universitario Marqués de Valdecilla
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- June 30, 2007
- Completion date
- December 31, 2011
- Enrollment
- 23 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.